BNTC
Benitec Biopharma·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
BNTC fundamentals
Benitec Biopharma (BNTC) released its earnings on May 14, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -0.24 (YoY +85.37%), missed estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.24
+85.37%
Report date
May 14, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Benitec Biopharma (BNTC) key financial stats and ratios, covering profitability, financial health, and leverage.
Benitec Biopharma (BNTC)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Benitec Biopharma (BNTC)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Benitec Biopharma (BNTC)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Benitec Biopharma (BNTC) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Benitec Biopharma (BNTC) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the market's earnings forecast for Benitec Biopharma next quarter?What does Benitec Biopharma do and what are its main business segments?What were the key takeaways from Benitec Biopharma’s earnings call?What were the key takeaways from Benitec Biopharma's earnings call?What factors drove the changes in Benitec Biopharma's revenue and profit?What guidance did Benitec Biopharma's management provide for the next earnings period?What is Benitec Biopharma's latest dividend and current dividend yield?What is Benitec Biopharma's gross profit margin?
